Japan Clears Extraction Catheter Distributed By Nihon Kohden
This article was originally published in PharmAsia News
Executive Summary
Japanese regulators have cleared Nihon Kohden's extraction catheter for marketing. The Pronto V3 is made by Vascular Solutions of the United States, but distributed in Japan by Nihon. The companies expect the catheter to launch in Japan as early as the third quarter. The device is designed to provide aspiration removal of acute thrombus from the arterial system. (Click here for more
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.